Lukusa T, Fryns J P, van den Berghe H
Clin Genet. 1986 Apr;29(4):311-6. doi: 10.1111/j.1399-0004.1986.tb01259.x.
In this report we summarize our experience in 4 patients with 45,X/46,XY, one patient with 45,X/47,XYY mosaicism, and one patient with 46,XY karyotype and ambiguous external genitalia. In the 3 patients with a fluorescent Y-chromosome, the development of one or two gonadoblastomas was found, independent of the age of the patients at the time of examination. In the 3 patients with 45,X/46,XYnf mosaicism no gonadoblastoma was detected. This finding prompted us to review the data on patients reported with 45,X/46,XYnf mosaicism. Up to now, no patient with well documented 45,X/46,XYnf mosaicism and convincing evidence of development of gonadoblastoma has been reported. These data seem to confirm that alterations of the characteristic distal fluorescence of Yq may protect the dysgenetic gonad against tumoral degeneration in patients with 45,X/46,XY mosaicism. Possible mechanisms responsible for these changes in the oncogenic potential of Yq in relation with the Y chromosome fluorescence are discussed.
在本报告中,我们总结了4例45,X/46,XY患者、1例45,X/47,XYY嵌合体患者以及1例具有46,XY核型和外生殖器模糊的患者的诊疗经验。在3例具有荧光Y染色体的患者中,发现了一或两个性腺母细胞瘤的发生,这与检查时患者的年龄无关。在3例45,X/46,XYnf嵌合体患者中未检测到性腺母细胞瘤。这一发现促使我们回顾已报道的45,X/46,XYnf嵌合体患者的数据。截至目前,尚未有关于45,X/46,XYnf嵌合体且有确凿证据表明发生性腺母细胞瘤的患者的报道。这些数据似乎证实,Yq特征性远端荧光的改变可能会保护45,X/46,XY嵌合体患者发育异常的性腺免于肿瘤性退变。讨论了Yq致癌潜能与Y染色体荧光相关的这些变化的可能机制。